Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

Vermont has opened registration to those 80 and older who are eligible for a booster shot of Pfizer’s COVID-19 vaccine. The state’s announcement on Thursday came hours after an advisory group within ...

The group will discus and vote on whether to recommend Pfizer booster shots. The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest ...

Vaccine makers are preparing for a next possible phase of the COVID-19 vaccine rollout: booster doses. Currently three coronavirus vaccines are authorized for emergency use in the United States -- the ...

A small percentage of Americans are eligible right now to get an extra layer of protection against COVID-19 and its variants; the rest of us will have to wait. People who are moderately to severely ...

Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

On Tuesday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Pfizer vaccine should now seek out a booster shot five months after ...

WASHINGTON — Pfizer and Moderna say the Food and Drug Administration have opened up COVID-19 booster shots to all adults, letting them choose another dose of either vaccine. The move expands the ...

RUNNEMEDE, New Jersey (WPVI) -- This week, Pfizer asked the FDA for authorization of a second COVID-19 booster shot for senior citizens to fight waning immunity. On Thursday, Moderna asked for that ...

Pfizer on Monday announced it submitted data to the Food and Drug Administration regarding the results of Phase 1 trials for a potential COVID-19 vaccine booster shot. In a press release, Pfizer said ...